These distinct enriched processes included regulation of signaling pathways, such as ‘platelet-derived growth factor receptor signaling pathway’ and ‘positive regulation of transforming growth factor beta production’ and might reflect true broader regulatory consequences downstream of SIX1-Q177R in Wilms tumors. The gene discussed is SIX1; the disease is Nephroblastoma.